Literature DB >> 33395578

Racial/Ethnic Differences in the Risk of Surgical Complications and Posthysterectomy Hospitalization among Women Undergoing Hysterectomy for Benign Conditions.

Lisa M Pollack1, Jerry L Lowder2, Matt Keller2, Su-Hsin Chang2, Sarah J Gehlert2, Margaret A Olsen2.   

Abstract

STUDY
OBJECTIVE: Evaluate whether 30- and 90-day surgical complication and postoperative hospitalization rates after hysterectomy for benign conditions differ by race/ethnicity and whether the differences remain after controlling for patient, hospital, and surgical characteristics.
DESIGN: Retrospective cohort study using administrative data. The exposure was race/ethnicity. The outcomes included 5 different surgical complications/categories and posthysterectomy inpatient hospitalization, all identified through 30 and 90 days after hysterectomy hospital discharge, with the exception of hemorrhage/hematoma, which was only identified through 30 days. To examine the association between race/ethnicity and each outcome, we used logistic regression with clustering of procedures within hospitals, adjusting for patient and hospital characteristics and surgical approach.
SETTING: Multistate, including Florida and New York. PATIENTS: Women aged ≥18 years who underwent hysterectomy for benign conditions using State Inpatient Databases and State Ambulatory Surgery Databases.
INTERVENTIONS: Hysterectomy for benign conditions.
MEASUREMENTS AND MAIN RESULTS: We included 183 697 women undergoing hysterectomy for benign conditions from January 2011 to September 2014. In analysis, adjusting for surgery route and other factors, black race was associated with increased risk of 30-day digestive system complications (multivariable adjusted odds ratio [aOR], 1.98; 95% confidence interval [CI], 1.78-2.21), surgical-site infection (aOR, 1.34; 95% CI, 1.18-1.53), posthysterectomy hospitalization (aOR, 1.31; 95% CI, 1.22-1.40), and urologic complications (aOR, 1.16; 95% CI, 1.01-1.34) compared with white race. Asian/Pacific Islander race was associated with increased risk of 30-day urologic complications (aOR, 1.48; 95% CI, 1.08-2.03), intraoperative injury to abdominal/pelvic organs (aOR, 1.46; 95% CI, 1.23-1.75), and hemorrhage/hematoma (aOR, 1.33; 95% CI, 1.06-1.67) compared with white race. Hispanic ethnicity was associated with increased risk of 30-day posthysterectomy hospitalization (aOR, 1.11; 95% CI, 1.02-1.20) compared with white race. All findings were similar at 90 days.
CONCLUSION: Black and Asian/Pacific Islander women had higher risk of some 30- and 90-day surgical complications after hysterectomy than white women. Black and Hispanic women had higher risk of posthysterectomy hospitalization. Intervention strategies aimed at identifying and better managing disparities in pre-existing conditions/comorbidities could reduce racial/ethnic differences in outcomes.
Copyright © 2021 AAGL. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adverse outcomes; Disparities; Healthcare cost and utilization project; Minimally invasive surgery

Mesh:

Year:  2021        PMID: 33395578      PMCID: PMC8211024          DOI: 10.1016/j.jmig.2020.12.032

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  42 in total

1.  Uterine weight and complications after abdominal, laparoscopic, and vaginal hysterectomy.

Authors:  Michelle Louie; Paula D Strassle; Janelle K Moulder; A Mitch Dizon; Lauren D Schiff; Erin T Carey
Journal:  Am J Obstet Gynecol       Date:  2018-06-28       Impact factor: 8.661

2.  Underlying reasons associated with hospital readmission following surgery in the United States.

Authors:  Ryan P Merkow; Mila H Ju; Jeanette W Chung; Bruce L Hall; Mark E Cohen; Mark V Williams; Thomas C Tsai; Clifford Y Ko; Karl Y Bilimoria
Journal:  JAMA       Date:  2015-02-03       Impact factor: 56.272

3.  Examining Disparities in Route of Surgery and Postoperative Complications in Black Race and Hysterectomy.

Authors:  Amy L Alexander; Anna E Strohl; Stephanie Rieder; Jane Holl; Emma L Barber
Journal:  Obstet Gynecol       Date:  2019-01       Impact factor: 7.661

4.  Relationship between Race/Ethnicity and Hysterectomy Outcomes for Benign Gynecologic Conditions.

Authors:  Olga Bougie; Sukhbir S Singh; Innie Chen; Ellen P McCarthy
Journal:  J Minim Invasive Gynecol       Date:  2018-05-25       Impact factor: 4.137

5.  Incidence and risk factors of early postoperative small bowel obstruction in patients undergoing hysterectomy for benign indications.

Authors:  David Sheyn; C Emi Bretschneider; Sangeeta T Mahajan; Beri Ridgeway; Abigail Davenport; Robert Pollard
Journal:  Am J Obstet Gynecol       Date:  2018-11-22       Impact factor: 8.661

Review 6.  Surgical outcomes for low-volume vs high-volume surgeons in gynecology surgery: a systematic review and meta-analysis.

Authors:  Alex Mowat; Christopher Maher; Emma Ballard
Journal:  Am J Obstet Gynecol       Date:  2016-03-03       Impact factor: 8.661

7.  Developing a risk stratification model for surgical site infection after abdominal hysterectomy.

Authors:  Margaret A Olsen; James Higham-Kessler; Deborah S Yokoe; Anne M Butler; Johanna Vostok; Kurt B Stevenson; Yosef Khan; Victoria J Fraser
Journal:  Infect Control Hosp Epidemiol       Date:  2009-11       Impact factor: 3.254

8.  Minimally invasive specialists and rates of laparoscopic hysterectomy.

Authors:  Megan Loring; Stephanie N Morris; Keith B Isaacson
Journal:  JSLS       Date:  2015 Jan-Mar       Impact factor: 2.172

9.  Updated hysterectomy surveillance and factors associated with minimally invasive hysterectomy.

Authors:  Sarah L Cohen; Allison F Vitonis; Jon I Einarsson
Journal:  JSLS       Date:  2014 Jul-Sep       Impact factor: 2.172

10.  Hysterectomy for benign conditions: Complications relative to surgical approach and other variables that lead to post-operative readmission within 90 days of surgery.

Authors:  Neal M Lonky; Yasmina Mohan; Vicki Y Chiu; Jeanna Park; Seth Kivnick; Christina Hong; Sharon M Hudson
Journal:  Womens Health (Lond)       Date:  2017-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.